Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises GE Real Estate in connection with sale of real estate portfolio to, and investment in, real estate fund
Mandate

Vinge advises GE Real Estate in connection with sale of real estate portfolio to, and investment in, real estate fund

January 13, 2009

Vinge has advised GE Real Estate Sweden AB in connection with the sale of a real estate portfolio consisting of approximately 30 properties to the newly started Roxanne Fastighetsfond.

The properties are situated in 15 municipalities in Sweden and comprise approximately 230,000 square metres of lettable space.

GE Real Estate has also invested in Roxanne Fastighetsfond. Other investors in the fund include Folksam Mutual Property Insurance Society (Sw. Folksam ömsesidig sakförsäkring), KPA Pensionsförsäkring AB (publ), Kåpan Pensions Insurance Society (Sw. Kåpan Pensioner Försäkringsförening), Vattenfall Pensions Foundation (Sw.Vattenfalls Pensionsstiftelse) and the Swedish Foundation for Strategic Research.

In connection with the transaction, Roxanne Fastighetsfond has also executed a management agreement with GE Real Estate concerning management of the company’s investments.

Vinge’s team consisted of partners Mattias Schömer, Rikard Stenberg and Stefan de Hevesy together with associates Petter Alberts, Sara Axelsson, Caroline Gebauer, Henrik Fritz and Johan Norström.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024